Attributes | Values |
---|
rdf:type
| |
Description
| - Interferon-alpha (IFN-alpha) is an important drug used in anti-melanoma therapy. However, metastases eventually reappear in almost 60% of melanoma patients, who have received adjuvant cytokine therapy suggesting that IFN-alpha can paradoxically promote disease progression in some cases, at least. In this study, we have investigated the possibility that a growth-promoting STAT3 protein might be activated by interferon-alpha in melanoma cells.
- Interferon-alpha (IFN-alpha) is an important drug used in anti-melanoma therapy. However, metastases eventually reappear in almost 60% of melanoma patients, who have received adjuvant cytokine therapy suggesting that IFN-alpha can paradoxically promote disease progression in some cases, at least. In this study, we have investigated the possibility that a growth-promoting STAT3 protein might be activated by interferon-alpha in melanoma cells. (en)
|
Title
| - Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein
- Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein (en)
|
skos:prefLabel
| - Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein
- Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein (en)
|
skos:notation
| - RIV/00209805:_____/09:#0000095!RIV10-MZ0-00209805
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(GA301/06/0912), Z(AV0Z50040507), Z(AV0Z50040702), Z(MZ0MOU2005)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00209805:_____/09:#0000095
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Malignant melanoma, interferons, STAT3 activation, disease outcome (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - European journal of cancer
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Krejčí, Eva
- Boudný, Vladimír
- Kovařík, Jan
- Fait, Vuk
- Humpolíková-Adámková, Lenka
- Lauerová, Ludmila
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
is http://linked.open...avai/riv/vysledek
of | |